Publications by authors named "Annette Lasham"

Claim this Profile
A
Analysis of HER2-Low Breast Cancer in Aotearoa New Zealand: A Nationwide Retrospective Cohort Study.
Annette Lasham, Reenadevi Ramsaroop, Abbey Wrigley, Nicholas Knowlton

Cancers (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining TP53 mutation and isoform has the potential to improve clinical practice.
Sankalita Ray Das, Brett Delahunt, Annette Lasham, Kunyu Li, Deborah Wright

Pathology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic ctDNA Mutational Complexity in Patients with Melanoma Receiving Immunotherapy.
Sandra Fitzgerald, Cherie Blenkiron, Rosalie Stephens, Jon A Mathy, Tiffany Somers-Edgar, Annette Lasham

Mol Diagn Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Close Links between Cold Shock Proteins and Cancer.
Mahmoud Toulany, Annette Lasham

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast Cancer Patient Prognosis Is Determined by the Interplay between Mutation and Alternative Transcript Expression: Insights from Long Amplicon Digital PCR Assays.
Annette Lasham, Nicholas Knowlton, Sunali Y Mehta, Antony W Braithwaite, Cristin G Print

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intronic Polymorphisms Are Associated with Increased Transcript, Immune Infiltration and Cancer Risk.
Ramona A Eiholzer, Sunali Mehta, Marina Kazantseva, Catherine J Drummond, Cushla McKinney, Annette Lasham

Cancers (Basel)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Predictor of Early Disease Recurrence in Patients With Breast Cancer Using a Cell-free RNA and Protein Liquid Biopsy.
Annette Lasham, Sandra J Fitzgerald, Nicholas Knowlton, Tamsin Robb, Peter Tsai

Clin Breast Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accessing a New Dimension in TP53 Biology: Multiplex Long Amplicon Digital PCR to Specifically Detect and Quantitate Individual Transcripts.
Annette Lasham, Peter Tsai, Sandra J Fitzgerald, Sunali Y Mehta, Nicholas S Knowlton

Cancers (Basel)· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orthogonal assays for the identification of inhibitors of the single-stranded nucleic acid binding protein YB-1.
AlexanderJ Trevarton, Yan Zhou, Dehua Yang, Gordon W Rewcastle, Jack U Flanagan, Annette Lasham

Acta Pharm Sin B· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypes.
Sunali Y Mehta, Brianna C Morten, Jisha Antony, Luke Henderson, Annette Lasham

Oncotarget· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma.
Thomas G Johnson, Karin Schelch, Yuen Y Cheng, Marissa Williams, Kadir H Sarun, Annette Lasham

J Thorac Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiling of breast tumours from New Zealand patients.
Anita Muthukaruppan, Annette Lasham, Cherie Blenkiron, Kathryn J Woad, Michael A Black

N Z Med J· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of biodegradable PLGA nanoparticles surface engineered with hyaluronic acid for targeted delivery of paclitaxel to triple negative breast cancer cells.
Brenda Brenner S Cerqueira, Annette Lasham, Andrew N Shelling, Raida Al-Kassas

Mater Sci Eng C Mater Biol Appl· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal Assessment of Estrogen Receptor mRNA Profiles to Quantify Estrogen Pathway Activity in Breast Tumors.
Anita Muthukaruppan, Annette Lasham, Kathryn J Woad, Michael A Black, Cherie Blenkiron

Clin Breast Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Study of TP53 RNA Splicing Illustrates Pitfalls of RNA-seq Methodology.
Sunali Mehta, Peter Tsai, Annette Lasham, Hamish Campbell, Roger Reddel

Cancer Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel EGR-1 dependent mechanism for YB-1 modulation of paclitaxel response in a triple negative breast cancer cell line.
Annette Lasham, Sunali Y Mehta, Sandra J Fitzgerald, Adele G Woolley, James I Hearn

Int J Cancer· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticle therapeutics: Technologies and methods for overcoming cancer.
Brenda Brenner S Cerqueira, Annette Lasham, Andrew N Shelling, Raida Al-Kassas

Eur J Pharm Biopharm· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticulate carriers: an emerging tool for breast cancer therapy.
Priyanka Tharkar, Asad Ullah Madani, Annette Lasham, Andrew N Shelling, Raida Al-Kassas

J Drug Target· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Links between the oncoprotein YB-1 and small non-coding RNAs in breast cancer.
Cherie Blenkiron, Daniel G Hurley, Sandra Fitzgerald, Cristin G Print, Annette Lasham

PLoS One· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-methyl-D-aspartate receptors amplify activation and aggregation of human platelets.
Maggie L Kalev-Zylinska, Taryn N Green, Marie-Christine Morel-Kopp, Paul P Sun, Young-Eun Park, Annette Lasham

Thromb Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YB-1: oncoprotein, prognostic marker and therapeutic target?
Annette Lasham, Cristin G Print, Adele G Woolley, Sandra E Dunn, Antony W Braithwaite

Biochem J· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancers.
Anna L Stratford, Kristen Reipas, Kaiji Hu, Abbas Fotovati, Rachel Brough, Annette Lasham

Stem Cells· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YB-1, the E2F pathway, and regulation of tumor cell growth.
Annette Lasham, Weini Samuel, Helen Cao, Rachna Patel, Reena Mehta

J Natl Cancer Inst· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic association of YB-1 expression in breast cancers: a matter of antibody.
Adele G Woolley, Michael Algie, Weini Samuel, Rhodri Harfoot, Anna Wiles, Annette Lasham

PLoS One· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of RT-qPCR primer design for the detection of siRNA-mediated mRNA silencing.
Mike Herbert, Natacha Coppieters, Annette Lasham, Helen Cao, Glen Reid

BMC Res Notes· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis